Table 3. Concentrations of hs-cTn-I in patients with RA receiving different drugs (n = 164).
Current Drug Therapy | n | hs-cTn-I, pg/mL | P value* |
On methotrexate | 118 | 1.170 (0.732–1.802) | 0.897 |
Not on methotrexate | 46 | 1.08 (0.723–1.997) | |
On anti-TNF drug | 34 | 0.980 (0.750–1.627) | 0.734 |
Not on anti-TNF drug | 130 | 1.175 (0.723–1.952 | |
On hydroxychloroquine | 42 | 1.095 (0.730–1.655) | 0.428 |
Not on hydroxychloroquine | 122 | 1.170 (0.732–1.927 | |
On corticosteroids | 88 | 1.175 (0.737–1.942) | 0.343 |
Not on corticosteroids | 76 | 1.115 (0.728–1.787) |
Wilcoxon’s rank sum test.